Clinical Trial Update: Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Fluorothiazinone for the prophylaxis of nosocomial Gram-negative infections in patients on mechanical ventilation; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia Gram-negative
• Infection Gram-negative
• Pneumonia Gram-negative

Drugs mentioned

• Fluorothiazinone (Fluorothiazinone)

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: Gram Negative Pneumonia, Gram-Negative Bacterial Infections | Phase 2 | Status: RECRUITING